Cullinan Associates’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,000
| Closed | -$229K | – | 224 |
|
|
2024
Q4 | $229K | Hold |
1,000
| – | – | 0.01% | 210 |
|
|
2024
Q3 | $240K | Sell |
1,000
-2,000
| -67% | -$479K | 0.01% | 220 |
|
|
2024
Q2 | $574K | Sell |
3,000
-1,000
| -25% | -$191K | 0.03% | 175 |
|
|
2024
Q1 | $792K | Sell |
4,000
-2,300
| -37% | -$455K | 0.04% | 169 |
|
|
2023
Q4 | $1.08M | Sell |
6,300
-800
| -11% | -$138K | 0.06% | 140 |
|
|
2023
Q3 | $1.05M | Sell |
7,100
-2,400
| -25% | -$355K | 0.06% | 141 |
|
|
2023
Q2 | $2.08M | Buy |
+9,500
| New | +$2.08M | 0.11% | 120 |
|
|
2022
Q1 | – | Sell |
-800
| Closed | -$208K | – | 243 |
|
|
2021
Q4 | $208K | Buy |
+800
| New | +$208K | 0.01% | 227 |
|